LT3001-201: A Phase IIa, Double-Blind, Single Dose, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Potential Efficacy of LT3001 Drug Product in Subjects with Acute Ischemic Stroke (AIS)

  • Pettigrew, Luther (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/22/2010/6/21